British Medical Journal Supplement Reports on 'Remarkable Era' of Improvement in Cystic Fibrosis Care

A decade of strategic efforts to improve care has played a profound role in improving the quality and length of life for people with cystic fibrosis in the United States, according to a series of reports published in the April issue of BMJ Quality & Safety (formerly the British Medical Journal).

| 2 min read

During this “remarkable era,” the CF Foundation launched an aggressive and innovative program to partner with CF care experts nationwide to test and adopt healthcare improvement strategies in Foundation-accredited CF care centers.

The BMJ supplement, Ten Years of Improvement Innovation in Cystic Fibrosis Care, includes key strategies proven to improve health outcomes, such as:

  • Fostering patient and family involvement in improving care;
  • Using patient registry data to track and improve outcomes; and
  • Encouraging collaboration between care centers to promote best practices and standardization of care across centers.

“As the mother of an adolescent with cystic fibrosis, I'm grateful for the CF Foundation's leadership in creating a culture that sets the bar high and strives for exemplary care,” said Kathryn Sabadosa, author of one of the reports in the supplement.

The supplement was co-edited by Bruce Marshall, senior vice president of clinical affairs of the CF Foundation, and David Stevens, adjunct professor of the Dartmouth Institute for Health Policy and Clinical Practice.

The Foundation's healthcare improvement programs have been recognized by the National Committee for Quality Assurance and the Alliance for Pediatric Quality.

Additional Resources:

  • Read the co-authors' editorial: “A decade of healthcare improvement in cystic fibrosis: lessons for other chronic diseases.”
  • Learn how to partner with your care center to improve care. 
Share this article
Topics
About the CF Foundation | Care Centers | Patient Registry
Recent news
Cystic Fibrosis Foundation Invests an Additional $5 Million in BiomX
News | 2 min read
Cystic Fibrosis Foundation Invests More Than $6.6 Million in Additional Funding in Sionna Therapeutics
News | 2 min read
Bruce Marshall, Chief Medical Officer, to Retire From the CF Foundation
News | 3 min read
You might also be interested in...
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe